Alavert

This page contains recent news articles, when available, and an overview of Alavert but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.


Overview:

Alavert
(when available)

Pharmacology and use:
Loratadine, a non-sedating H1-blocker similar in structure to cyproheptadine and azatadine, is used to treat seasonal allergic rhinitis. Unlike other H1-blockers, loratidine does not penetrate the CNS effectively and has a low affinity for CNS H1-receptors. For the relief of nasal and non-nasal symptoms of seasonal allergic rhinitis and for the treatment of chronic idiopathic urticaria in patients 2 years of age or older

Mechanism Of Action:
Like other H1-blockers, loratadine competes with free histamine for binding at H1-receptors in the GI tract, uterus, large blood vessels, and bronchial muscle. Loratadine also has a weak affinity for acetylcholine and alpha-adrenergic receptors.

News Articles on Loratadine

Generic Name: Loratadine, Claritine, Clarityn, Clarityne, Fristamin, Lorfast ...  -  ‎Nov 11, 2009‎
...brand names: Claritine / Clarityn / Clarityne / Fristamin / Lorfast / Lomilan / Symphoral / Roletra / Rinolan / AllergyX / Alavert / Tidilor) is an ... Pattaya Daily News

Pfizer returns to consumer care with Wyeth buy  -  ‎Oct 19, 2009‎
...sales (down 1%) and $53.4 million in Caltrate sales (up 3.8%); cold and allergy, where in addition to Advil Cold, Wyeth fields Alavert and Robitussin. ... Drug Store News (blog)

Rite Aid Wants Diabetics to 'Stay Healthy'  -  ‎Oct 27, 2009‎
Participating brands, which have included Procter & Gamble's Olay, Kimberly-Clark's Huggies, J&J's Aveeno and Wyeth's Alavert, are identified in stores with ... In-Store Marketing Institute (subscription)

Brand Names/Synonyms:
Alavert is also known by the following brand names and/or synonymsAerotina; Alarin; Alavert; Alerpriv; Allertidin; Bedix Loratadina; Biloina; Bonalerg; CHEMBANK1389; Civeran; Claratyne; Claratyne Cold; Claratyne Decongestant; Clarinase; Clarinase Reperabs; Clarinex; Claritin; Claritin Reditab; Claritin Reditabs; Claritin-D; Claritine; Clarityn; Clarityne; Fristamin; Histaloran; Lergy; Lertamine; Lesidas; Lisino; Loracert; Loradex; Loradif; Loranox; Lorantis; Lorastine; Loratadina [Spanish]; Loratadine; Loratadine [Usan:Ban:Inn]; Loratadinum [Latin]; Loratyne; Loraver; Lorfast; Loritine; Lowadina; Nularef; Optimin; Polaratyne; Pylor; Restamine; Rhinase; Rinomex; Sanelor; Sensibit; Sinhistan Dy; Sohotin; Tadine; Talorat Dy; Velodan; Versal; Zeos

Drug Category:
Alavert is categorized under the following by the FDA: Anti-allergic Agents; Antipruritics; Antihistamines; Histamine H1 Antagonists, Non-Sedating; ATC:R06AX13; ATC:R06AX27

Dosage Forms:
Tablet; Syrup

Absorption:
Loratadine was rapidly absorbed following oral administration (40% bioavailability)

Interactions:
[an error occurred while processing this directive]



Chemical IUPAC Name:
4-(8-chloro-5,6-dihydro-11H-benzo[5,6]cyclohepta[1,2-b]pyridin-11-ylidene)-1-piperidinecarboxylic acid ethyl ester





Health Home | Conditions | Cancer | Medications | Surgery | Vaccines


The Cancer News Network


Disclaimer:

Contact a physician with regard to health concerns. Email requests for further health information will be discarded.

The materials contained on this Web site are for informational purposes only and do not constitute health or medical advice. Use of information on this site does not create or constitute any kind of agreement or contract between you and the owners or users of this site, the owners of the servers upon which it is housed, or anyone else who is in any way connected with this site.

Many links on cancernewsnetwork.org lead to other sites. cancernewsnetwork.org does not sponsor, endorse or otherwise approve of the materials appearing in such sites. Nor is CancerNewsNetwork.org responsible for dead or misdirected links.

IF YOU NEED A LINK OR TEXT REMOVED FROM THIS PAGE PLEASE CONTACT cancernewsnetwork (at) live.com.
We will do our best to accommodate your request.



COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy